Trevi Therapeutics Statistics
Total Valuation
TRVI has a market cap or net worth of $213.69 million. The enterprise value is $148.54 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TRVI has 76.87 million shares outstanding. The number of shares has increased by 1.57% in one year.
Current Share Class | 76.87M |
Shares Outstanding | 76.87M |
Shares Change (YoY) | +1.57% |
Shares Change (QoQ) | +0.24% |
Owned by Insiders (%) | 1.19% |
Owned by Institutions (%) | 39.02% |
Float | 47.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.54 |
P/TBV Ratio | 3.69 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.38, with a Debt / Equity ratio of 0.02.
Current Ratio | 7.38 |
Quick Ratio | 7.21 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -6,887.71 |
Financial Efficiency
Return on equity (ROE) is -59.65% and return on invested capital (ROIC) is -39.89%.
Return on Equity (ROE) | -59.65% |
Return on Assets (ROA) | -36.57% |
Return on Capital (ROIC) | -39.89% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.77M |
Employee Count | 25 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -28,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +99.28% in the last 52 weeks. The beta is 1.01, so TRVI's price volatility has been similar to the market average.
Beta (5Y) | 1.01 |
52-Week Price Change | +99.28% |
50-Day Moving Average | 3.12 |
200-Day Moving Average | 2.90 |
Relative Strength Index (RSI) | 41.52 |
Average Volume (20 Days) | 523,249 |
Short Selling Information
The latest short interest is 1.72 million, so 2.23% of the outstanding shares have been sold short.
Short Interest | 1.72M |
Short Previous Month | 1.52M |
Short % of Shares Out | 2.23% |
Short % of Float | 3.59% |
Short Ratio (days to cover) | 3.78 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -48.21M |
Pretax Income | -38.78M |
Net Income | -44.32M |
EBITDA | -48.07M |
EBIT | -48.21M |
Earnings Per Share (EPS) | -$0.44 |
Full Income Statement Balance Sheet
The company has $65.49 million in cash and $1.11 million in debt, giving a net cash position of $64.38 million or $0.84 per share.
Cash & Cash Equivalents | 65.49M |
Total Debt | 1.11M |
Net Cash | 64.38M |
Net Cash Per Share | $0.84 |
Equity (Book Value) | 58.97M |
Book Value Per Share | 0.78 |
Working Capital | 58.21M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$35.07 million and capital expenditures -$50,000, giving a free cash flow of -$35.12 million.
Operating Cash Flow | -35.07M |
Capital Expenditures | -50,000 |
Free Cash Flow | -35.12M |
FCF Per Share | -$0.46 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |